C

Capricor

32 open positions
Last updated Jul 31, 2026
Remote12%
Hybrid6%
On-site82%
Salary shown99%
Avg. listing80d
This month0 new · 0 closed

Quality Control Associate II, Controls

$75k–$87k/year
41
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

OtherQuality Control AssociateFull-Time (Exempt)Mid
See 2 similar>
5 0 0 5mo ago

Quality Control Scientist, Controls

$95k–$115k/year
41
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

OtherQuality ControlFull-Time (Exempt)Mid
See 2 similar>
4 0 0 5mo ago

Quality Control Specialist, Analytical

$75k–$95k/year
41
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

Quality Control SpecialistLaboratory & Life SciencesFull-Time (Exempt)Mid
See 2 similar>
3 0 0 5mo ago

MSAT Associate 2

$73k–$88k/year
41
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

OtherAssociateFull-Time (Exempt)Mid
See 2 similar>
4 0 0↻ Repost 5mo ago

Scientist – Preclinical Team

$95k–$115k/year
41
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

OtherScientistFull-Time (Exempt)Mid
See 2 similar>
6 0 0 5mo ago

Program Manager, Commercial Operations

$100k–$140k/year
44
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

OtherCommercial OperationsFull-Time (Exempt)Mid
See 2 similar>
7 0 0 5mo ago

Quality Control Scientist

$100k–$115k/year
42
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

OtherQuality ControlFull-Time (Exempt)Mid
See 2 similar>
3 0 0 5mo ago
C
Capricor·San Diego - Sd1·On-site

Manufacturing Technician

$23–$25/hour
41
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

OtherManufacturing TechnicianFull-Time (Non-Exempt)Mid
See 2 similar>
3 0 0↻ Repost 5mo ago

MSAT Training Specialist II/III

$75k–$95k/year
42
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

Learning & Development SpecialistPeopleFull-Time (Exempt)Mid
See 2 similar>
3 0 0 5mo ago

Facilities Associate II / III

$73k–$88k/year
41
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

OtherFacilities AssociateFull-Time (Exempt)Mid
See 2 similar>
1 0 0 5mo ago

Warehouse Supervisor

$80k–$95k/year
42
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

Logistics & Supply ChainWarehouse SupervisorFull-Time (Exempt)Mid
See 2 similar>
8 0 0 6mo ago

Quality Assurance Associate II

$70k–$82k/year
42
Low

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We a

OtherQA & TestingQuality Assurance AssociateQuality Assurance LeadFull-Time (Exempt)Mid
See 4 similar>
8 0 0 12mo ago